Singapore, Sept. 25 -- The Health Sciences Authority received information related to the study titled 'Evaluating the Year-Round Immunogenicity of Standard-Dose Versus High-Dose Seasonal Influenza Vaccines in Adults Aged 60 Years or Older in Singapore (SingVax-01)'. The following are the other relevant details related to the trial:
Therapeutic Area: Infectious Diseases
Trial Centre(s):
Tan Tock Seng Hospital
Trial Status: NA
Principal Investigator(s):
Dr Barnaby Young
Published by HT Digital Content Services with permission from Health Daily Digest....